North America Patient Engagement Solutions Market Research Report: By Component (Software, Hardware, Services), Delivery Mode (Web Based, Cloud Based, On-Premise), Application (Health Management, Home Health Management, Social & Behavioral Management, Financial Health Management), Therapeutic Area (Chronic Diseases, Women Health, Fitness, Mental Health), End User (Providers, Payers, Individual) – Industry Size, Share, Growth, Trends and Forecast to 2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Component

1.3.2 Market Segmentation by Delivery Mode

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by Therapeutic Area

1.3.5 Market Segmentation by End User

1.3.6 Market Segmentation by Geography

1.3.7 Analysis Period

1.3.8 Market Data Reporting Unit

1.3.8.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By country

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Component

4.1.1.1 Software

4.1.1.1.1 Integrated software

4.1.1.1.2 Standalone software

4.1.1.2 Hardware

4.1.1.3 Services

4.1.1.3.1 Consulting services

4.1.1.3.2 Education services

4.1.1.3.3 Others

4.1.2 By Delivery Mode

4.1.2.1 Web based

4.1.2.2 Cloud based

4.1.2.3 On-premise

4.1.3 By Application

4.1.3.1 Health management

4.1.3.2 Home health management

4.1.3.3 Social and behavior management

4.1.3.4 Financial health management

4.1.4 By Therapeutic Area

4.1.4.1 Chronic diseases

4.1.4.1.1 Cardiovascular diseases

4.1.4.1.2 Cancer

4.1.4.1.3 Diabetes

4.1.4.1.4 Obesity

4.1.4.1.5 Others

4.1.4.2 Women health

4.1.4.3 Fitness

4.1.4.4 Mental health

4.1.4.5 Others

4.1.5 By End User

4.1.5.1 Providers

4.1.5.2 Payers

4.1.5.3 Individuals

4.1.5.4 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing adoption of cloud-based models

4.2.2 Drivers

4.2.2.1 Implementation of government regulations and initiatives to promote patient-centric care

4.2.2.2 Implementation of value-based programs

4.2.2.3 Growing use of patient engagement solutions among the aging population

4.2.2.4 Increasing healthcare cost

4.2.2.5 Increasing utilization of mobile health solutions

4.2.2.6 Increasing demands of wearable health technology

4.2.2.7 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Protection of patient information

4.2.3.2 Poor medication adherence

4.2.3.3 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Threat of New Entrants

4.3.4 Intensity of Rivalry

4.3.5 Threat of Substitutes

Chapter 5. North America Market Size and Forecast

5.1 By Component

5.1.1 Patient Engagement Software Market by Type

5.1.2 Patient Engagement Services Market by Type

5.2 By Delivery Mode

5.3 By Application

5.4 By Therapeutic Area

5.4.1 Patient Engagement Solutions Market for Chronic Diseases by Type

5.5 By End User

5.6 By Country

5.6.1 U.S. Patient Engagement Solutions Market

5.6.1.1 By component

5.6.1.1.1 Patient engagement software market by type

5.6.1.1.2 Patient engagement services market by type

5.6.1.2 By delivery mode

5.6.1.3 By application

5.6.1.4 By therapeutic area

5.6.1.4.1 Patient engagement solutions market for chronic diseases by type

5.6.1.5 By end user

5.6.2 Canada Patient Engagement Solutions Market

5.6.2.1 By component

5.6.2.1.1 Patient engagement software market by type

5.6.2.1.2 Patient engagement services market by type

5.6.2.2 By delivery mode

5.6.2.3 By application

5.6.2.4 By therapeutic area

5.6.2.4.1 Patient engagement solutions market for chronic diseases by type

5.6.2.5 By end user

Chapter 6. Competitive Landscape

6.1 Product Benchmarking of Key Players

6.2 Strategic Developments of Key Players in North America

6.2.1 Mergers and Acquisitions

6.2.2 Product Launches

6.2.3 Partnerships

Chapter 7. Company Profiles

7.1 Allscripts Healthcare Solutions Inc.

7.1.1 Business Overview

7.1.2 Product and Service Offerings

7.1.3 Key Financial Summary

7.2 McKesson Corporation

7.2.1 Business Overview

7.2.2 Product and Service Offerings

7.2.3 Key Financial Summary

7.3 athenahealth Inc.

7.3.1 Business Overview

7.3.2 Product and Service Offerings

7.3.3 Key Financial Summary

7.4 International Business Machines Corporation (IBM)

7.4.1 Business Overview

7.4.2 Product and Service Offerings

7.4.3 Key Financial Summary

7.5 Cerner Corporation

7.5.1 Business Overview

7.5.2 Product and Service Offerings

7.5.3 Key Financial Summary

7.6 Lincor Inc.

7.6.1 Business Overview

7.6.2 Product and Service Offerings

Chapter 8. Appendix

8.1 Abbreviations

8.2 Sources and References

8.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2013 – 2017)

TABLE 3 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2018 – 2023)

TABLE 4 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2013 – 2017)

TABLE 5 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2018 – 2023)

TABLE 6 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2013 – 2017)

TABLE 7 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2018 – 2023)

TABLE 8 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2013 – 2017)

TABLE 9 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2018 – 2023)

TABLE 10 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2013 – 2017)

TABLE 11 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2018 – 2023)

TABLE 12 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2013 – 2017)

TABLE 13 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2018 – 2023)

TABLE 14 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2013 – 2017)

TABLE 15 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2018 – 2023)

TABLE 16 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2013 – 2017)

TABLE 17 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2018 – 2023)

TABLE 18 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2013 – 2017)

TABLE 19 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2018 – 2023)

TABLE 20 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2013 – 2017)

TABLE 21 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2018 – 2023)

TABLE 22 U.S. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2013 – 2017)

TABLE 23 U.S. PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2018 – 2023)

TABLE 24 U.S. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2013 – 2017)

TABLE 25 U.S. PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2018 – 2023)

TABLE 26 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2013 – 2017)

TABLE 27 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2018 – 2023)

TABLE 28 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2013 – 2017)

TABLE 29 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2018 – 2023)

TABLE 30 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2013 – 2017)

TABLE 31 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2018 – 2023)

TABLE 32 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2013 – 2017)

TABLE 33 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2018 – 2023)

TABLE 34 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2013 – 2017)

TABLE 35 U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2018 – 2023)

TABLE 36 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2013 – 2017)

TABLE 37 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2018 – 2023)

TABLE 38 CANADA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2013 – 2017)

TABLE 39 CANADA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2018 – 2023)

TABLE 40 CANADA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2013 – 2017)

TABLE 41 CANADA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2018 – 2023)

TABLE 42 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2013 – 2017)

TABLE 43 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2018 – 2023)

TABLE 44 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2013 – 2017)

TABLE 45 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2018 – 2023)

TABLE 46 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2013 – 2017)

TABLE 47 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2018 – 2023)

TABLE 48 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2013 – 2017)

TABLE 49 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2018 – 2023)

TABLE 50 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2013 – 2017)

TABLE 51 CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2018 – 2023)

TABLE 52 ALLSCRIPTS HEALTHCARE SOLUTIONS INC.– AT A GLANCE

TABLE 53 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.– KEY FINANCIAL SUMMARY

TABLE 54 MCKESSON CORPORATION – AT A GLANCE

TABLE 55 ATHENAHEALTH, INC. – AT A GLANCE

TABLE 56 ATHENAHEALTH INC. – KEY FINANCIAL SUMMARY

TABLE 57 IBM CORPORATION– AT A GLANCE

TABLE 58 IBM CORPORATION– KEY FINANCIAL SUMMARY

TABLE 59 CERNER CORPORATION – AT A GLANCE

TABLE 60 CERNER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 61 LINCOR INC. – AT A GLANCE

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY COUNTRY

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET SUMMARY

FIG 9 PREPAID PRIVATE EXPENDITURE PER CAPITA ON HEALTH IN NORTH AMERICA (2007–2017)

FIG 10 IMPACT ANALYSIS: DRIVERS

FIG 11 IMPACT ANALYSIS: RESTRAINTS

FIG 12 PORTER’S FIVE FORCES ANALYSIS

FIG 13 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT

FIG 14 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, $M (2013 – 2023)

FIG 15 NORTH AMERICA PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, $M (2013 – 2023)

FIG 16 NORTH AMERICA PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, $M (2013 – 2023)

FIG 17 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, $M (2013 – 2023)

FIG 18 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 19 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, $M (2013 – 2023)

FIG 20 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, $M (2013 – 2023)

FIG 21 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, $M (2013 – 2023)

FIG 22 NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 23 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 24 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.– REVENUE SPLIT BY SEGMENT (2023)

FIG 25 MCKESSON CORPORATION REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 26 IBM CORPORATION – REVENUE SPLIT BY SEGMENT AND BY GEOGRAPHY (2023)

FIG 27 CERNER CORPORATION – REVENUE SPLIT BY SOLUTIONS & SERVICES AND SEGMENT (2023)